| Literature DB >> 23867771 |
Abstract
Substantial epidemiological evidence shows an increased risk for developing Alzheimer's disease (AD) in people with diabetes. Yet the underlying molecular mechanisms still remain to be elucidated. This article reviews the current studies on common pathological processes of Alzheimer's disease and diabetes with particular focus on potential mechanisms through which diabetes affects the initiation and progression of Alzheimer's disease. Impairment of insulin signaling, inflammation, oxidative stress, mitochondrial dysfunction, advanced glycation end products, APOEε4 and cholesterol appear to be important mediators and are likely to act synergistically in promoting AD pathology.Entities:
Keywords: AD; APP; Alzheimer’s disease; Aβ; BACE1; GSK3β; IDE; IGF; NSAID; amyloid β precursor protein; amyloid β protein; diabetes; glycogen synthase kinase 3β; hIAPP; human islet amyloid polypeptide; insulin-degrading enzyme; insulin-like growth factor; molecular links; non-steroidal anti-inflammatory drug; β-site APP-cleaving enzyme 1
Mesh：
Substances：
Year: 2013 PMID： 23867771 DOI： 10.1016/j.neuroscience.2013.07.009
Source DB: PubMed Journal: Neuroscience ISSN： 0306-4522 Impact factor: 3.590